The full chain gathers strength, innovates and links the global market - the 2026 World Pharmaceutical Raw Materials China Exhibition is about to land in Shanghai

1、 Exhibition Basic Official Information

1. Organizer：Informa Markets、 Jointly organized by the China Chamber of Commerce for Import and Export of Medicines and Health Products and Shanghai Bohua International Exhibition Co., Ltd., the exhibition industry is authoritative and internationally recognized, ranking among the top tier of domestic pharmaceutical exhibitions.
2. Date and location of the eventJune 16-18, 2026, for a period of three days; The venue for the event is the Shanghai New International Expo Center (Pudong), which will utilize all the main exhibition halls to achieve large-scale expansion of the exhibition area.
3. Overall scale of the exhibitionThe official estimate is that the total exhibition area will exceed 240000 square meters, gathering more than 3600 exhibiting companies from around the world, covering more than 30 countries and regions; It is expected to receive over 110000 professional visitors from domestic and foreign purchasers, R&D personnel, industry investors, and other professionals, making it the largest professional trade exhibition in the domestic pharmaceutical industry in the first half of the year.
4. Core positioning of the exhibitionBuild a two-way communication bridge for Chinese pharmaceutical companies to connect with overseas markets, localize procurement for overseas pharmaceutical companies, and implement cutting-edge pharmaceutical technologies, to help the domestic pharmaceutical industry integrate into the global pharmaceutical supply chain system.

2、 Top 10 professional exhibition areas layout, covering the entire pharmaceutical industry chain

1. Chemical API and Intermediates Exhibition Area: Focusing on APIs, pharmaceutical intermediates, and customized synthetic chemicals, covering the full range of basic chemical raw materials to high-end specialty APIs, it is the core area for global API procurement;
2. Biotechnology exhibition area: focusing on showcasing biopharmaceutical raw materials, cell and gene therapy, mRNA technology, and bioprocessing solutions, in line with the current trend of biopharmaceutical innovation;
3. Pharmaceutical excipients and formulations exhibition area: covering various types of pharmaceutical excipients and new functional excipients, showcasing high-end formulation research and development achievements, and filling the gaps in the formulation industry chain;
4. Pharmaceutical Equipment and Intelligent Manufacturing Exhibition Area: Linking PMEC exhibition resources, showcasing automated production lines, intelligent testing equipment, and clean engineering systems, focusing on the digital upgrading of the pharmaceutical industry;
5. Pharmaceutical Packaging Materials Exhibition Area: Focusing on green biodegradable pharmaceutical packaging, intelligent anti-counterfeiting packaging, and sterile packaging materials, in response to the environmental protection and carbon reduction policies of the pharmaceutical industry;
6. Exhibition Area for Natural Extracts and Traditional Chinese Medicine Raw Materials: Focusing on medicinal and edible raw materials, plant extracts, and deep processed products of traditional Chinese medicine, we aim to open up international trade channels for traditional Chinese medicine;
7. CMO/CDMO Contract Customization Service Exhibition Area: Bringing together pharmaceutical R&D outsourcing and production outsourcing enterprises to help pharmaceutical companies shorten the new drug R&D cycle and reduce industrialization costs;
8. Animal health and animal medicine raw materials exhibition area: covering animal medicine raw materials, pet medicine raw materials, and feed additives, laying out the rapidly growing pet medicine blue ocean market;
9. Pharmaceutical Cold Chain Logistics Exhibition Area: Showcasing low-temperature warehousing, temperature controlled transportation packaging, full traceability cold chain equipment, suitable for the transportation needs of biopharmaceuticals and high-end injections;
10. Exhibition Area for Life Science Instruments and Reagents: Covering laboratory analytical instruments, R&D reagents, quality control testing equipment, serving the entire process of pharmaceutical front-end R&D.

3、 Simultaneous heavyweight forum activities, targeting the forefront pain points of the industry

1. This exhibition is accompanied by over a hundred professional conferences and technical seminars, all of which focus on industry regulatory policies, overseas trade, and core pain points of process upgrading;
2. The Core Brand Summit includes the Global API Compliance and Going Global Forum, Biomedical Innovation Summit, Pharmaceutical Industry Dual Carbon and Green Production Forum, and Pharmaceutical Intelligent Manufacturing Digital Transformation Conference;
3. The forum invites experts from domestic and foreign drug regulatory agencies, executives from multinational pharmaceutical companies, R&D leaders from top pharmaceutical companies, and third-party analysts in the industry to share on-site, interpreting the latest pharmaceutical registration regulations, export trade barriers, and new environmental production standards at home and abroad, providing authoritative references for enterprises to avoid business risks.

4、 Highlights of the 2026 Exhibition Core Upgrade

1. Expansion and upgrading of international exhibition areas: exclusive national pavilions will be added to mainstream pharmaceutical trade regions such as Europe, Southeast Asia, and India, and the number of overseas exhibiting companies will steadily increase year-on-year, further strengthening the ability to connect with global commerce;
2. Establish a dedicated area for green pharmaceuticals: focusing on environmentally friendly synthesis processes, low-carbon treatment technologies for wastewater and waste gas, and solvent-free production processes, in line with the dual carbon development goals of the pharmaceutical industry;
3. Online Business Matching System: Visitors and exhibitors can make appointments in advance for one-on-one negotiations, breaking the time limit for offline exhibitions and improving the efficiency of supply and demand matching;
4. Focusing on the opportunities of patent cliff: The special forum discussed industry hotspots such as centralized procurement policies, expiration of drug patents, and layout of generic drugs, which are in line with the current development needs of domestic pharmaceutical companies.

5、 The value and significance of the exhibition industry

1. Commercial value: Providing a one-stop platform for upstream and downstream enterprises to purchase, attract investment, and negotiate cooperation, effectively shortening the supply and demand docking link of the pharmaceutical industry chain, and reducing the cost of customer acquisition for enterprises;
2. Industrial value: Concentrate on showcasing the digital and green transformation achievements of the domestic pharmaceutical industry, showcasing the industrial advantages of China's raw materials and biopharmaceutical fields, and consolidating China's core position in the global pharmaceutical supply chain;
3. Development value: Relying on the exhibition platform to synchronously convey the latest development trends of the global pharmaceutical industry, helping domestic pharmaceutical companies accurately layout overseas markets, while introducing advanced pharmaceutical technology and management experience from overseas, promoting high-quality innovative development of the domestic pharmaceutical industry.